You may soon be able to eat your Ozempic… sort of. GLP-1 supplements are booming, promising to deliver similar benefits to ...

G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Supergut is setting sights on bold retail expansion with the help of fresh capital and new executive leadership with a track ...

This month pharmacies will no longer be allowed to sell lower-cost compounded versions of the anti-obesity drug tirzepatide — ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

Consumers taking GLP-1 drugs like Ozempic will need to adapt their shopping habits and diets, opening opportunities for food ...

A product development expert explains how the swift rise of these anti-obesity medications is fueling new food trends.

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

Gut health brand Supergut has secured new capital from Full Frame Growth Partners, and brought in former CEO of Vital Proteins as CEO.